InIn vitro effects of extracts of extra virgin olive oil on human colon cancer cells

Nutrition and Cancer

Volumn 66, Issue 7, 2014, Pages 1228-1236

  Pampaloni, Barbara ^a   Mavilia, Carmelo ^a   Fabbri, Sergio ^a   Romani, Annalisa ^a   Ieri, Francesca ^a   Tanini, Annalisa ^a   Tonelli, Francesco ^a   Brandi, Maria Luisa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTYROSOL; ANTINEOPLASTIC AGENT; BAG 1 PROTEIN; DEACETOXY OLEUROPEIN AGLYCONE; DNA METHYLTRANSFERASE 1; ELENOLIC ACID; ELENOLIC ACID DERIVATIVE; ESTRADIOL; ESTROGEN RECEPTOR BETA; EXTRA VIRGIN OLIVE OIL; HYDROXYTYROSOL; LIGNAN; LIGNAN DERIVATIVE; LIGSTROSIDE AGLYCONE DERIVATIVE; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLEOCANTHAL; OLEUROPEIN AGLYCONE; OLIVE OIL; PHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; PROTEIN; PROTEIN BRCA; PROTEIN P53; PROTEIN TRIM 25; SECOIRIDOID; TRANSCRIPTION FACTOR SOX4; TYROSOL; UNCLASSIFIED DRUG; WNT PROTEIN; POLYPHENOL; TRANSCRIPTOME; VEGETABLE OIL;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STIMULATION; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; EMBRYO DEVELOPMENT; ESTROGEN ACTIVITY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WNT SIGNALING PATHWAY; COLON TUMOR; DNA MICROARRAY; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; ESTRADIOL; ESTROGEN RECEPTOR BETA; HUMANS; LIGNANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLANT OILS; POLYPHENOLS; TRANSCRIPTOME;

EID: 84908145252     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.951727     Document Type: Article

References (63)

1. Llor X., Pons E., Roca A., Alvarez M., Mañé J, et al.: The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. Clin Nutr 22, 71-79, 2003.
2. Hashim YZ., Eng M., Gill CI., McGlynn H., and Rowland IR.: Components of olive oil and chemoprevention of colorectal cancer. Nutr Rev 63, 374-386, 2005.
3. Wahle KWJ., Caruso D., Ochoa JJ., and Quiles JL.: Olive oil and modulation of cell signaling in disease prevention. Lipids 39, 1223-1231, 2004.
4. Bartoli R., Fernández-Bañares F., Navarro E., Castellà E., Mañé J, et al.: Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 46, 191-199, 2000.
5. Raju J., Bielecki A., Caldwell D., Lok E., Taylor M, et al.: Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre-and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta. J Nutr 139, 474-481, 2009.
6. Visioli F., Poli A., and Galli C.: Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev 22, 65-75, 2002.
7. Vissers M., Zock PL., Roodenburg AJ., Leenen R., and Katan MB.: Olive oil phenols are absorbed in humans. J Nutr 132, 409-417, 2002.
8. Owen RW., Mier W., Giacosa A., Hull WE., Spiegelhalder B, et al.: Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoroids, lignans and squalene. Food Chem Toxicol 38, 647-659, 2000.
9. Fini L., Hotchkiss E., Fogliano V., Graziani G., Romano M, et al.: Chemopreventive properties of pinoresinol-rich olive oil involve a selective activation of the ATM-p53 cascade in colon cancer cell lines. Carcinogenesis 29, 139-146, 2008.
10. Adlercreutz H., Bannwart C., Wähälä K., Mäkelä T., Brunow G, et al.: Inhibition of human aromatase by mammalian lignans and isoflavoid phytoestrogens. J Steroid Biochem Mol Biol 44, 147-153, 1993.
11. Owen RW., Giacosa A., Hull WE., Haubner R., Spiegelhalder B, et al.: The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur J Cancer, 36, 1235-1247, 2000.
12. Campbell-Thompson M., Lynch IJ., and Bhardwaj B.: Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 61, 632-640, 2001.
13. Martineti V., Picariello L., Tognarini I., Carbonell Sala S., Gozzini A, et al.: ERβ is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Rel Cancer 12, 455-469, 2005.
14. Fiorelli G., Picariello L., Martineti V., Tonelli F., and Brandi ML.: Estrogen synthesis in human colon cancer epithelial cells. J Steroid Biochem Mol Biol 71, 223-230, 1999.
15. Picariello L., Fiorelli G., Martineti V., Tognarini I., Pampaloni B, et al.: Growth response of colon cancer cell lines to selective estrogen receptor modulators. Anticancer Res 23, 2419-2424, 2003.
16. Foley EF., Jazaeri AA., Shupnik MA., Jazaeri O., and Rice LW.: Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 60, 245-248, 2000.
17. Tompkins WA., Watrach AM., Schmale JD., Schultz RM., and Harris JA.: Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst 52, 1101-1110, 1974.
18. Romani A., Pinelli P., Mulinacci N., Galardi C., Vincieri FF, et al.: HPLC and HRGC analyses of polyphenols and secoiridoids in olive oil. Chromatographia 53, 279-284, 2001.
19. Mulinacci N., Giaccherini C., Ieri F., Innocenti M., Romani A, et al.: Evaluation of lignans and free and linked hydroxy-tyrosol and tyrosol in extra virgin olive oil after hydrolysis processes. J Sci Food Agric 86, 757-764, 2006.
20. Beauchamp GK., Keast RS., Morel D., Lin J., Pika J, et al.: Phytochemistry: Ibuprofen-like activity in extra-virgin olive oil. Nature 437, 45-46, 2005.
21. Van Gelder RN., von Zastrow ME., Yool A., Dement WC., Barchas JD, et al.: Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci 87, 1663-1667, 1990.
22. Yang YH., Dudoit S., Luu P., Lin DM., Peng V, et al.: Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30, 15, 2002.
23. Newton MA., Kendziorski CM., Richmond CS., Blattner FR., and Tsui KW.: On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J Comput Biol 8, 37-52, 2001.
24. Cutress RI., Townsend PA., Brimmell M., Bateman AC., Hague A, et al.: BAG-1 expression and function in human cancer. Br J Cancer 87, 834-839, 2002.
25. Meloche S. and Pouysségur J.: The ERK1/2 mitogen-activated protein kinase pathway as a master regulator ofthe G1-to S-phase transition. Oncogene 26, 3227-3239, 2007.
26. Lefebvre V., Dumitriu B., Penzo-Méndez A., Han Y., and Pallavi B.: Control of cell fate and differentiation by Sry-related high-mobility-group Box (Sox) transcription factors. Int J Biochem Cell Biol 39, 2195-2214, 2007.
27. Venkitaraman AR.: Chromosome stability, DNA recombination and the BRCA2 tumour suppressor. Curr Opin Cell Biol 13, 338-343, 2001.
28. Dimitriadis A., Vincan E., Mohammed IM., Roczo N., Phillips WA, et al.: Expression of Wnt genes in human colon cancers. Cancer Lett 166, 185-191, 2001.
29. Wu Q., Burghardt R., and Safe S.: Vitamin D-interacting protein 205 (DRIP205) coactivation of estrogen receptor alpha (ERalpha) involves multiple domains of both proteins. J Biol Chem 279, 53602-53612, 2004.
30. Jair KW., Bachman KE., Suzuki H., Ting AH., Rhee I, et al.: De novo CpG island methylation in human cancer cells. Cancer Res 66, 682-692, 2006.
31. Horie K., Urano T., Ikeda K., and Inoue S.: Estrogen-responsive RING finger protein controls breast cancer growth. J Steroid Biochem Mol Biol 85, 101-104, 2003.
32. Blok LJ., Grossmann ME., Perry JE., and Tindall DJ.: Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol Endocrinol 9, 1610-1620, 1995.
33. Colomer R. and Menéndez JA.: Mediterranean diet, olive oil and cancer. Clin Transl Oncol 8, 15-21, 2006.
34. Waterman E. and Lockwood B.: Active components and clinical applications of olive oil. Altern Med Rev 12, 331-342, 2007.
35. Visioli F., Bellomo G., and Galli C.: Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 247, 60-64, 1998.
36. Carluccio MA., Siculella L., Ancora MA., Massaro M., Scoditti E, et al.: Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23, 622-629, 2003.
37. Gill CI., Boyd A., McDermott E., McCann M., Servili M, et al.: Potential anti-cancer effects of virgin olive oil phenols on colorectal carcinogenesis models in vitro. Int J Cancer 117, 1-7, 2005
38. Arai N., Ström A., Rafter JJ., and Gustafsson JA.: Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun 270, 425-431, 2000.
39. Russo J., Lareef MH., Tahin Q., Hu YF., Slater C, et al.: 17β-estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol 80, 149-162, 2002.
40. Cutress RI., Townsend PA., Brimmell M., Bateman AC., Hague A, et al.: BAG-1 expression and function in human cancer. Br J Cancer 87, 834-839, 2002.
41. Sun N., Meng Q., Tian A.: Expressions of the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their relationship. Am J Surg 200, 341-345, 2010.
42. Lefebvre V., Dumitriu B., Penzo-Méndez A., Han Y., and Pallavi B.: Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol 39, 2195-2214, 2007.
43. Dimitriadis A., Vincan E., Mohammed IM., Roczo N., Phillips WA, et al.: Expression of Wnt genes in human colon cancers. Cancer Lett 166, 185-191, 2001.
44. Venkitaraman AR.: Chromosome stability, DNA recombination and the BRCA2 tumour suppressor. Curr Opin Cell Biol 13, 338-343, 2001.
45. Chen GG., Zeng Q., and Tse GM.: Estrogen and Its Receptors in Cancer. Med Res Rev 28, 954-974, 2008
46. Barnes JD., Arhel NJ., Lee SS., Sharp A., Al-Okail M, et al.: Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells. Apoptosis 10, 301-311, 2005.
47. Tang D., Wu D., Hirao A., Lahti JM., Liu L, et al.: ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem, 277, 12710-12717, 2002.
48. Wang YK., Zhu YL., Qiu FM., Zhang T., Chen ZG, et al.: Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133. Carcinogenesis 31, 1376-1380, 2010.
49. Deng CX. and Wang RH.: Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum Mol Genet 12, R113-R123, 2003.
50. Brody LC. and Biesecker BB.: Breast cancer susceptibility genes.BRCA1 and BRCA2. Medicine (Baltimore) 77, 208-226, 1998.
51. Boulton SJ.: Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans 34, 633-645, 2006.
52. Hur W., Rhim H., Jung CK., Kim JD., Bae SH, et al.: SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis 31, 1298-1307, 2010.
53. Aaboe M., Birkenkamp-Demtroder K., Wiuf C., Sørensen FB., Thykjaer T, et al.: SOX4 Expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res 66 (7), 3434-3442, 2006.
54. Andersen CL., Christensen LL., Thorsen K., Schepeler T., Sørensen FB, et al.: Dysregulation of the transcription factors SOX4, CBFB andSMARCC1 correlates with outcome of colorectal cancer. Br J Cancer 100, 511-523, 2009.
55. Van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I, et al.: The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-50, 2002.
56. De Lau W., Barker N., and Clevers H.: WNT signaling in the normal intestine and colorectal cancer. Front Biosci 12, 471-491, 2007.
57. Van der Flier LG. and Clevers H.: Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71, 241-260, 2009.
58. Logan CY. and Nusse R.: The WNT signaling pathway in development and disease. Annu Rev Cell Dev Biol 20, 781-810 2004
59. Kirikoshi H., Sekihara H., and Katoh M.: WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly coexpressed in SW480 cells. Biochm Biophys Res Commun 283, 798-805, 2001.
60. Wang LS., Arnold M., Huang YW., Sardo C., Seguin C, et al.: Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase i pilot study. Clin Cancer Res 17, 598-610, 2011.
61. Blok LJ., Grossmann ME., Perry JE., and Tindall DJ.: Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol Endocrinol 9, 1610-1620, 1995.
62. Kumbrink J. and Kirsch KH.: Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2. Neoplasia 14, 108-120, 2012.
63. Asgari M. and Morakabati A.: Estrogen receptor beta expression in prostate adenocarcinoma. Diagn Pathol 6; 61, 2011.